Related Experiment Videos
[In vitro activity of fosfomycin]
Archivio Per Le Scienze Mediche
|April 1, 1980
Summary
Phosphomycin demonstrates excellent in vitro activity against a wide range of bacteria, including gram-positive and gram-negative strains. Its high efficacy against common hospital-acquired pathogens suggests its utility in clinical settings.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Context:
- Hospital-acquired infections are a growing concern.
- Gram-negative bacterial infections are increasingly prevalent in healthcare settings.
- Evaluating novel and existing antibiotic efficacy is crucial for treatment guidelines.
Purpose:
- To compare the in vitro activity of phosphomycin against other antibiotics.
- To assess phosphomycin's effectiveness on various bacterial strains isolated from clinical specimens.
- To determine phosphomycin's potential role in combating hospital-acquired infections.
Summary:
- Phosphomycin was tested in vitro against 1703 bacterial strains from pathological specimens.
- It showed high sensitivity rates against Staphylococcus (97.4%), E. coli (86.7%), Proteus mirabilis (73.1%), and Citrobacter (68.6%).
- Phosphomycin also exhibited significant activity against Pseudomonas (54.6%) and indole-positive Proteus (48.2%).
Impact:
- Phosphomycin exhibits broad-spectrum activity against clinically relevant bacterial pathogens.
- Its effectiveness against gram-negative bacteria supports its consideration for routine use in hospitals.
- This study highlights phosphomycin as a valuable therapeutic option for managing bacterial infections.